- Home
- BYSI vs CURR Comparison
BYSI vs CURR Comparison
Compare BYSI & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYSI
- CURR
- Stock Information
- Founded
- BYSI 2010
- CURR 2013
- Country
- BYSI United States
- CURR Singapore
- Employees
- BYSI N/A
- CURR N/A
- Industry
- BYSI Biotechnology: Pharmaceutical Preparations
- CURR Business Services
- Sector
- BYSI Health Care
- CURR Consumer Discretionary
- Exchange
- BYSI Nasdaq
- CURR Nasdaq
- Market Cap
- BYSI 71.0M
- CURR 74.0M
- IPO Year
- BYSI 2017
- CURR N/A
- Fundamental
- Price
- BYSI $2.23
- CURR $1.04
- Analyst Decision
- BYSI
- CURR Strong Buy
- Analyst Count
- BYSI 0
- CURR 1
- Target Price
- BYSI N/A
- CURR $3.50
- AVG Volume (30 Days)
- BYSI 152.4K
- CURR 8.6M
- Earning Date
- BYSI 08-11-2025
- CURR 08-11-2025
- Dividend Yield
- BYSI N/A
- CURR N/A
- EPS Growth
- BYSI N/A
- CURR N/A
- EPS
- BYSI N/A
- CURR N/A
- Revenue
- BYSI N/A
- CURR $43,386,858.00
- Revenue This Year
- BYSI N/A
- CURR N/A
- Revenue Next Year
- BYSI N/A
- CURR $21.53
- P/E Ratio
- BYSI N/A
- CURR N/A
- Revenue Growth
- BYSI N/A
- CURR N/A
- 52 Week Low
- BYSI $0.98
- CURR $0.33
- 52 Week High
- BYSI $3.44
- CURR $7.08
- Technical
- Relative Strength Index (RSI)
- BYSI 46.60
- CURR N/A
- Support Level
- BYSI $2.33
- CURR N/A
- Resistance Level
- BYSI $2.50
- CURR N/A
- Average True Range (ATR)
- BYSI 0.32
- CURR 0.00
- MACD
- BYSI -0.10
- CURR 0.00
- Stochastic Oscillator
- BYSI 1.59
- CURR 0.00
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants world-wide, delivering frictionless interoperable real-time fund transfers and instant messaging.